BODY SYSTEM / ADVERSE
EXPERIENCE |
Bupropion
sustained-release Dosing Group |
||
100-200 mg/d (N=350) |
300-400 mg/d (N=343) |
Placebo (N=235) |
|
Vomiting |
2.9% |
2.9% |
1.3% |
Toothache/Tooth
Abscess |
2.0% |
1.7% |
3.0% |
Flatulence |
3.7% |
1.5% |
1.7% |
Body
(General) |
|||
Headache |
30.3% |
25.7% |
26.8% |
Chest
Pain |
1.4% |
2.9% |
0.9% |
Asthenia |
1.4% |
2.3% |
1.7% |
Back
Pain |
3.7% |
3.2% |
3.4% |
Fever |
1.1% |
2.3% |
0% |
Neck
Pain |
2.3% |
1.5% |
1.7% |
Accidental
Injury |
1.7% |
1.5% |
2.1% |
Respiratory System Disorders |
|||
Pharyngitis |
1.7% |
5.2% |
1.7% |
Rhinitis |
10.6% |
5.5% |
8.5% |
Sinusitis |
1.1% |
5.5% |
1.7% |
Respiratory
Complaints |
1.7% |
1.1% |
1.7% |
Skin
and Appendages Disorders |
|||
Sweating |
2.9% |
6.1% |
1.3% |
Rash |
2.6% |
5.2% |
0.9% |
Pruritus |
2.3% |
3.8% |
1.7% |
Urticaria |
0.6% |
1.5% |
0% |
Cardiovascular |
|||
Palpitations |
2.3% |
2.9% |
1.7% |
Migraine |
1.7% |
1.7% |
1.3% |
Hot
Flashes |
1.4% |
1.5% |
1.3% |
Hypertension |
1.7% |
1.2% |
0.9% |
Tachycardia |
1.4% |
0.9% |
0.9% |
Back a Page
Next Page
Back to Wellbutrin SRŪ NDA Index Page
Back to Main
Index